|
6 Companies |
|
10 Products |
|
10 Products |
|
12 Mechanisms of Action |
|
0 Trials |
|
160 News |
|
| «1234» |
- Trial completion, Enrollment change: Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia (clinicaltrials.gov) - Dec 6, 2015
P2, N=38, Completed, Sponsor: Georgetown University
Active, not recruiting --> Completed | N=112 --> 38
- Trial completion, Enrollment change, Trial primary completion date: fMRI of Language Recovery Following Stroke in Adults (clinicaltrials.gov) - Nov 10, 2015
P=N/A, N=24, Completed, Sponsor: University of Alabama at Birmingham
Active, not recruiting --> Completed | N=112 --> 38 Active, not recruiting --> Completed | N=300 --> 24 | Trial primary completion date: Dec 2015 --> Aug 2015
- Trial primary completion date: Treatment Efficacy for Developmental Motor Speech Disorders (clinicaltrials.gov) - Nov 6, 2015
P=N/A, N=44, Recruiting, Sponsor: The Prompt Institute
Active, not recruiting --> Completed | N=300 --> 24 | Trial primary completion date: Dec 2015 --> Aug 2015 Trial primary completion date: Dec 2015 --> Dec 2016
- Enrollment closed, Trial primary completion date: An Assessment of the Prevalence of Spatial Neglect in Stroke Survivors With Aphasia (clinicaltrials.gov) - Sep 22, 2015
P1/2, N=105, Active, not recruiting, Sponsor: Kessler Foundation
Trial primary completion date: Dec 2015 --> Dec 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Dec 2016
- Trial completion: Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD (clinicaltrials.gov) - Sep 8, 2015
P=N/A, N=27, Completed, Sponsor: Mayo Clinic
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Dec 2016 Recruiting --> Completed
- Enrollment closed: Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia (clinicaltrials.gov) - Aug 14, 2015
P2, N=112, Active, not recruiting, Sponsor: Georgetown University
Recruiting --> Completed Recruiting --> Active, not recruiting
- Trial completion: Phonomotor Treatment of Word Retrieval Deficits in Individuals With Aphasia (clinicaltrials.gov) - Jul 16, 2015
P2, N=28, Completed, Sponsor: Department of Veterans Affairs
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial primary completion date: Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech (clinicaltrials.gov) - Jun 24, 2015
P=N/A, N=45, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Active, not recruiting --> Completed Trial primary completion date: Jun 2015 --> Dec 2015
- davunetide intranasal (AL-108) / Endo
Trial primary completion date: Davunetide (AL-108) in Predicted Tauopathies - Pilot Study (clinicaltrials.gov) - Jun 11, 2015
P2, N=12, Active, not recruiting, Sponsor: University of California, San Francisco
Trial primary completion date: Jun 2015 --> Dec 2015 Trial primary completion date: Dec 2014 --> Dec 2015
- Trial completion: Effect of Verb Network Strengthening Treatment (VNeST) on Lexical Retrieval in Aphasia (clinicaltrials.gov) - Jun 9, 2015
P2, N=11, Completed, Sponsor: Department of Veterans Affairs
Trial primary completion date: Dec 2014 --> Dec 2015 Active, not recruiting --> Completed
- ||||| LMTX (hydromethylthionine) / TauRx
Enrollment closed, Enrollment change: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) (clinicaltrials.gov) - Mar 20, 2015
P3, N=220, Active, not recruiting, Sponsor: TauRx Therapeutics Ltd
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=180 --> 220
- ||| Trial completion: PiB PET Scanning in Speech and Language Based Dementias (clinicaltrials.gov) - Mar 18, 2015
P=N/A, N=168, Completed, Sponsor: Mayo Clinic
Recruiting --> Active, not recruiting | N=180 --> 220 Recruiting --> Completed
- ||| Trial completion, Enrollment change, Trial primary completion date: FCET2EC: Effectiveness of Intensive Aphasia Therapy Under Routine Clinical Conditions (clinicaltrials.gov) - Feb 19, 2015
P=N/A, N=156, Completed, Sponsor: University Hospital Muenster
Recruiting --> Completed Active, not recruiting --> Completed | N=126 --> 156 | Trial primary completion date: Jul 2014 --> Jan 2015
- Phase classification: Aphasia Rehabilitation: Modulating Cues, Feedback & Practice (clinicaltrials.gov) - Feb 2, 2015
P=N/A, N=16, Recruiting, Sponsor: Rehabilitation Institute of Chicago
Active, not recruiting --> Completed | N=126 --> 156 | Trial primary completion date: Jul 2014 --> Jan 2015 Phase classification: P1 --> P=N/A
- Trial primary completion date: Transcranial Direct Current Stimulation and Aphasia Language Therapy (clinicaltrials.gov) - Feb 2, 2015
P1, N=12, Active, not recruiting, Sponsor: Rehabilitation Institute of Chicago
Phase classification: P1 --> P=N/A Trial primary completion date: Dec 2013 --> Dec 2015
- Trial completion, Enrollment change, Trial primary completion date: Transcranial Magnetic Stimulation to Improve Speech in Aphasia (clinicaltrials.gov) - Jan 30, 2015
P2, N=63, Completed, Sponsor: Boston University
Trial primary completion date: Dec 2013 --> Dec 2015 Active, not recruiting --> Completed | N=90 --> 63 | Trial primary completion date: Mar 2013 --> Jun 2013
- Trial completion, Enrollment change: Language Treatment for Progressive Aphasia (clinicaltrials.gov) - Jan 28, 2015
P=N/A, N=7, Completed, Sponsor: Baycrest
Active, not recruiting --> Completed | N=90 --> 63 | Trial primary completion date: Mar 2013 --> Jun 2013 Active, not recruiting --> Completed | N=14 --> 7
- Trial primary completion date: fMRI of Language Recovery Following Stroke in Adults (clinicaltrials.gov) - Jan 28, 2015
P=N/A, N=300, Active, not recruiting, Sponsor: University of Alabama at Birmingham
Active, not recruiting --> Completed | N=14 --> 7 Trial primary completion date: Dec 2014 --> Dec 2015
- Enrollment change, Trial initiation date, Trial primary completion date: Word-Retrieval Treatment for Aphasia: Semantic Feature Analysis (clinicaltrials.gov) - Dec 25, 2014
P=N/A, N=110, Completed, Sponsor: Department of Veterans Affairs
Trial primary completion date: Dec 2014 --> Dec 2015 N=10 --> 110 | Initiation date: Sep 2004 --> Jul 2005 | Trial primary completion date: Sep 2010 --> Feb 2009
- levodopa/benserazide / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Effect of Dopaminergic Medication on Recovery of Aphasia (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=12, Completed, Sponsor: University Hospital, Geneva
N=10 --> 110 | Initiation date: Sep 2004 --> Jul 2005 | Trial primary completion date: Sep 2010 --> Feb 2009 Enrolling by invitation --> Completed | N=15 --> 12 | Trial primary completion date: Dec 2009 --> Aug 2009
- Trial primary completion date: Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD (clinicaltrials.gov) - Nov 28, 2014
P=N/A, N=30, Recruiting, Sponsor: Mayo Clinic
Enrolling by invitation --> Completed | N=15 --> 12 | Trial primary completion date: Dec 2009 --> Aug 2009 Trial primary completion date: Oct 2014 --> Apr 2015
- Trial completion, Metastases: GIRDH: Internal Rotation Deficit of the Glenohumeral Joint in Advanced-level Handball Players (clinicaltrials.gov) - Nov 14, 2014
P=N/A, N=86, Completed, Sponsor: Centre Hospitalier Universitaire de Nīmes
Trial primary completion date: Oct 2014 --> Apr 2015 Active, not recruiting --> Completed
- Enrollment open: Brain Mechanisms Underlying Reading Improvement in Central Alexia (clinicaltrials.gov) - Oct 28, 2014
P=N/A, N=24, Recruiting, Sponsor: University College, London
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | Enrollment change: Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls. (clinicaltrials.gov) - Sep 19, 2014
P2, N=34, Completed, Sponsor: Avid Radiopharmaceuticals
Not yet recruiting --> Recruiting N=28 --> 34
- ||| Trial completion, Trial primary completion date: Longitudinal Study of Cognition With Niemann-Pick Disease, Type C (clinicaltrials.gov) - Sep 12, 2014
P=N/A, N=70, Completed, Sponsor: Mayo Clinic
N=28 --> 34 Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Sep 2014
- Enrollment open: Intensive Dysarthria Sessions in Adults and Children With Down Syndrome (clinicaltrials.gov) - Aug 11, 2014
P=N/A, N=12, Recruiting, Sponsor: Duke University
Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Sep 2014 Not yet recruiting --> Recruiting
- |||| LMTX (hydromethylthionine) / TauRx
Trial primary completion date: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) (clinicaltrials.gov) - Aug 6, 2014
P3, N=180, Recruiting, Sponsor: TauRx Therapeutics Ltd
Not yet recruiting --> Recruiting Trial primary completion date: Jul 2015 --> Dec 2015
- davunetide intranasal (AL-108) / Endo
Trial primary completion date: Davunetide (AL-108) in Predicted Tauopathies - Pilot Study (clinicaltrials.gov) - Jul 10, 2014
P2, N=12, Active, not recruiting, Sponsor: University of California, San Francisco
Trial primary completion date: Jul 2015 --> Dec 2015 Trial primary completion date: Dec 2013 --> Dec 2014
- Trial primary completion date: fMRI of Language Recovery Following Stroke in Adults (clinicaltrials.gov) - Jul 8, 2014
P=N/A, N=300, Active, not recruiting, Sponsor: University of Alabama at Birmingham
Trial primary completion date: Dec 2013 --> Dec 2014 Trial primary completion date: Jul 2014 --> Dec 2014
- Enrollment closed, Trial primary completion date: fMRI of Language Recovery Following Stroke in Adults (clinicaltrials.gov) - Jul 8, 2014
P=N/A, N=300, Active, not recruiting, Sponsor: University of Alabama at Birmingham
Trial primary completion date: Jul 2014 --> Dec 2014 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2014 --> Dec 2014
- Trial completion: Randomised Controlled Treatment Study of Selective Mutism (clinicaltrials.gov) - Jun 22, 2014
P2, N=24, Completed, Sponsor: Regionsenter for barn og unges psykiske helse
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2014 --> Dec 2014 Active, not recruiting --> Completed
- Enrollment change: Effect of Verb Network Strengthening Treatment (VNeST) on Lexical Retrieval in Aphasia (clinicaltrials.gov) - Jun 19, 2014
P2, N=11, Active, not recruiting, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Completed N=15 --> 11
- asenapine / Generic mfg.
Phase classification: A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering (clinicaltrials.gov) - Jun 12, 2014
P3, N=32, Suspended, Sponsor: University of California, Irvine
N=15 --> 11 Phase classification: P4 --> P3
- Enrollment closed: FCET2EC: Effectiveness of Intensive Aphasia Therapy Under Routine Clinical Conditions (clinicaltrials.gov) - May 19, 2014
P=N/A, N=126, Active, not recruiting, Sponsor: University Hospital Muenster
Phase classification: P4 --> P3 Recruiting --> Active, not recruiting
- asenapine / Generic mfg.
Trial primary completion date: A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering (clinicaltrials.gov) - May 18, 2014
P3, N=32, Suspended, Sponsor: University of California, Irvine
Recruiting --> Active, not recruiting Trial primary completion date: Sep 2013 --> May 2014
- asenapine / Generic mfg.
Trial suspension: A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering (clinicaltrials.gov) - May 18, 2014
P3, N=32, Suspended, Sponsor: University of California, Irvine
Trial primary completion date: Sep 2013 --> May 2014 Not yet recruiting --> Suspended
- Trial initiation date: Web-Based CBT Protocol for Treatment of Selective Mutism (clinicaltrials.gov) - May 18, 2014
P=N/A, N=38, Completed, Sponsor: National Healthcare Group, Singapore
Not yet recruiting --> Suspended Initiation date: Aug 2005 --> Jul 2005
- asenapine / Generic mfg.
Trial completion date: A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering (clinicaltrials.gov) - May 18, 2014
P3, N=32, Suspended, Sponsor: University of California, Irvine
Initiation date: Aug 2005 --> Jul 2005 Trial completion date: Dec 2013 --> May 2014
- Trial primary completion date: The Effects of Tactile Speech Feedback on Stuttering Frequency (clinicaltrials.gov) - May 8, 2014
P1, N=0, Withdrawn, Sponsor: University of Mississippi, Oxford
- Trial withdrawal: The Effects of Tactile Speech Feedback on Stuttering Frequency (clinicaltrials.gov) - May 8, 2014
P1, N=0, Withdrawn, Sponsor: University of Mississippi, Oxford
Trial completion date: Dec 2013 --> May 2014 Recruiting --> Withdrawn
- Trial completion date: The Effects of Tactile Speech Feedback on Stuttering Frequency (clinicaltrials.gov) - May 8, 2014
P1, N=0, Withdrawn, Sponsor: University of Mississippi, Oxford
- Enrollment change: The Effects of Tactile Speech Feedback on Stuttering Frequency (clinicaltrials.gov) - May 8, 2014
P1, N=0, Withdrawn, Sponsor: University of Mississippi, Oxford
Recruiting --> Withdrawn N=30 --> 0
- Trial primary completion date, Metastases: GIRDH: Internal Rotation Deficit of the Glenohumeral Joint in Advanced-level Handball Players (clinicaltrials.gov) - May 1, 2014
P=N/A, N=86, Active, not recruiting, Sponsor: Centre Hospitalier Universitaire de Nīmes
N=30 --> 0 Trial primary completion date: Aug 2014 --> Sep 2014
- Trial completion date, Metastases: GIRDH: Internal Rotation Deficit of the Glenohumeral Joint in Advanced-level Handball Players (clinicaltrials.gov) - May 1, 2014
P=N/A, N=86, Active, not recruiting, Sponsor: Centre Hospitalier Universitaire de Nīmes
Trial primary completion date: Aug 2014 --> Sep 2014 Trial completion date: Aug 2014 --> Sep 2014
- Enrollment change, Metastases: GIRDH: Internal Rotation Deficit of the Glenohumeral Joint in Advanced-level Handball Players (clinicaltrials.gov) - May 1, 2014
P=N/A, N=86, Active, not recruiting, Sponsor: Centre Hospitalier Universitaire de Nīmes
Trial completion date: Aug 2014 --> Sep 2014 N=120 --> 86
- Enrollment closed, Metastases: GIRDH: Internal Rotation Deficit of the Glenohumeral Joint in Advanced-level Handball Players (clinicaltrials.gov) - May 1, 2014
P=N/A, N=86, Active, not recruiting, Sponsor: Centre Hospitalier Universitaire de Nīmes
N=120 --> 86 Recruiting --> Active, not recruiting
- Zolinza (vorinostat) / Merck (MSD)
New P1/2 trial: Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1 (clinicaltrials.gov) - Apr 24, 2014
P1/2, N=15, Recruiting, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Enrollment change: Living With Frontotemporal Dementia (clinicaltrials.gov) - Apr 18, 2014
P=N/A, N=40, Recruiting, Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting --> Active, not recruiting N=60 --> 40
- | Trial completion: Evaluation of the Effects of Response Elaboration Training for Aphasia (clinicaltrials.gov) - Apr 13, 2014
P=N/A, N=47, Completed, Sponsor: Department of Veterans Affairs
N=60 --> 40 Recruiting --> Completed
- Enrollment open: Treatment Efficacy for Developmental Motor Speech Disorders (clinicaltrials.gov) - Apr 3, 2014
P=N/A, N=44, Recruiting, Sponsor: The Prompt Institute
Recruiting --> Completed Not yet recruiting --> Recruiting